Turning point of organoid transplantation:first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa

作     者：Chang-Jun Zhang Zi-Bing Jin 

作者机构：Beijing Institute of OphthalmologyBeijing Tongren HospitalCapital Medical UniversityBeijing 100730China 

出 版 物：《Science China(Life Sciences)》 (中国科学（生命科学英文版）)

年 卷 期：2024年第67卷第5期

页      面：1082-1084页

核心收录：

学科分类：0831[工学-生物医学工程（可授工学、理学、医学学位）] 1002[医学-临床医学] 08[工学] 100212[医学-眼科学] 0836[工学-生物工程] 10[医学] 

基　　金：partly supported by the National Science Fund for Distinguished Young Scholars(82125007) 

主　　题：conditions patients retinitis 

摘      要：The discovery of induced pluripotent stem cells(iPSCs)has revolutionized the field of disease research,providing a promising platform for studying various *** the last decade,significant progress has been made in combining iPSCs with other cutting-edge technologies to investigate disease mechanisms and develop potential treatments.